Meaning-Centered Therapy for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if Meaning-Centered Psychotherapy for Latinos (MCP-L) can more effectively reduce anxiety and depression in cancer patients compared to the usual cognitive behavioral therapy (CBT). Researchers also seek feedback from participants and therapists on the therapy and its various aspects. The trial seeks patients with advanced breast, prostate, colorectal, or thyroid cancer who speak Spanish and are receiving outpatient care. As an unphased trial, this study offers a unique opportunity to contribute to innovative research tailored for the Latino community.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that Meaning-Centered Psychotherapy for Latinos (MCP-L) is safe?
Research has shown that Meaning-Centered Psychotherapy for Latinos (MCP-L) is generally safe for participants. In a study involving 57 Latino cancer patients and their caregivers, 73.75% to 95.5% reported tolerating MCP-L well, indicating that most experienced no negative effects. MCP-L has been specially adapted to support the spiritual and emotional needs of Latino cancer patients, helping to reduce anxiety and depression. Although information on negative side effects is limited, the high satisfaction rates suggest that the therapy is comfortable and manageable for participants.12345
Why are researchers excited about this trial?
Meaning-Centered Psychotherapy for Latinos (MCP-L) is unique because it focuses on helping cancer patients find a sense of meaning and purpose in their lives, which is different from standard treatments like Cognitive Behavioral Therapy (CBT) that target changing thought patterns and behaviors. Researchers are excited about MCP-L because it addresses the emotional and existential distress that often accompanies cancer diagnoses, particularly in Latino communities. By honing in on cultural values and personal significance, MCP-L aims to improve the quality of life and emotional well-being of patients in ways that traditional therapies might not fully achieve.
What evidence suggests that Meaning-Centered Psychotherapy for Latinos could be effective for reducing anxiety and depression?
Research has shown that Meaning-Centered Psychotherapy for Latinos (MCP-L), which participants in this trial may receive, can reduce anxiety and depression in Latino cancer patients. A survey of Latino patients and caregivers found that 73.75% to 95.5% considered MCP helpful. This therapy aims to enhance spiritual well-being, which is crucial for overall quality of life. It has been specially adapted to meet the cultural needs of Latino patients, increasing its relevance and effectiveness. These findings suggest that MCP-L could be a promising approach to improving mental health for Latinos dealing with cancer.12345
Who Is on the Research Team?
Rosario Costas Muniz, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for Mexican adults with advanced breast, prostate, colorectal, or thyroid cancer. Participants should be experiencing emotional distress related to their condition. There are no specific inclusion criteria provided here, but typically participants must meet certain health conditions and agree to the study's procedures.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Meaning-Centered Psychotherapy for Latinos (MCP-L) or Cognitive Behavioral Therapy (CBT)
Follow-up
Participants are monitored for changes in anxiety and depression levels post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- Meaning-Centered Psychotherapy for Latinos /MCP-L
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor